1. Home
  2. LAES vs ATYR Comparison

LAES vs ATYR Comparison

Compare LAES & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$3.73

Market Cap

366.0M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.81

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
ATYR
Founded
2022
2005
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.0M
79.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
LAES
ATYR
Price
$3.73
$0.81
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$6.50
$8.75
AVG Volume (30 Days)
9.3M
2.1M
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,978,000.00
$190,000.00
Revenue This Year
$66.73
N/A
Revenue Next Year
$92.76
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$0.64
52 Week High
$9.50
$7.29

Technical Indicators

Market Signals
Indicator
LAES
ATYR
Relative Strength Index (RSI) 38.46 55.62
Support Level $3.83 $0.70
Resistance Level $4.76 $0.75
Average True Range (ATR) 0.32 0.05
MACD -0.02 0.01
Stochastic Oscillator 2.23 76.89

Price Performance

Historical Comparison
LAES
ATYR

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: